Much more interestingly, brain capillary damage and BBB breakdown in the hippocampus of individuals with early cognitive dysfunction were irrespective of the alterations of Aβ and/or tau pathologies, suggesting the promising potential as early biomarker for AD [24]. The gene discussed is MAPT; the disease is Alzheimer disease.